Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.The net outflow of the main market exceeded 10 billion.How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.
The retail sector moved up for 8 days and 5 boards of Zhongbai Group, while the retail sector moved up for 8 days and 5 boards of Zhongbai Group, with the daily limit of Youa shares, and Dashang shares, wenfeng shares, Xujiahui and Jiajiayue rose rapidly.Treasury futures collectively opened lower, with 30-year main contracts down 0.38%, 30-year main contracts down 0.38%, 10-year main contracts down 0.11%, 5-year main contracts down 0.06% and 2-year main contracts down 0.04%.Adani Port Company withdrew its loan request of US$ 553 million from the United States. On December 10th, local time, Adani Port Company stated that it would provide funds for its Colombo Port Terminal Project through internal accrual project and capital management plan, and withdrew its request for funds from DFC. DFC said last year that it would provide $553 million in financing for the port terminal project, which is partly owned by Adani Group. Last month, gautam Adani, the chairman of Adani Group, and seven other men were charged in the federal court in new york on suspicion of large-scale bribery and fraudulent schemes.
Dongxing Securities: The demand for food and beverage will pick up. Dongxing Securities Research Report pointed out that with the implementation of a series of policies such as expanding domestic demand and stabilizing investment, consumption will gradually stabilize and recover, and the demand for food and beverage will also pick up. In particular, catering consumption will recover with the economic recovery. It is expected that the upstream and downstream consumption of catering will improve, and the overall demand of liquor, condiments, beer and other industries is gradually recovering. Especially in the condiment industry, it is speculated that the whole industry is in destocking after the Mid-Autumn Festival. With the arrival of consumption in the peak season of New Year's Day and Spring Festival, the stocking period in the peak season is expected to start, and it is expected that mainstream condiment enterprises will achieve steady growth in the fourth quarter. At present, the overall valuation of the industry is lower than the historical average valuation, and there is room for repair. Continue to pay attention to liquor, snack food and condiments in the pro-cyclical sector of the food and beverage industry.Fosun's tourism culture premium is about 95%. Privatization resumed on December 11, and Fosun's tourism culture (01992) was announced. The company's shares resumed trading at 9: 00 am on December 11, 2024. Fosun's tourism culture plan was privatized by agreement and its listing status was revoked. The board of directors proposed to buy back shares at a price of HK$ 7.80 per share, which was 95% higher than the closing price before suspension.The first demonstration in China! Seiko Technology's high-performance PAN fiber technology has made key progress, and Seiko Technology's high-performance fiber precursor (polymerization process) "The first demonstration of safety and reliability of chemical process used in China" has successfully passed the evaluation of the expert group, which indicates that Seiko Technology's carbon fiber precursor preparation technology can be applied to industrialization on a large scale. On December 7th, Zhejiang Petroleum and Chemical Industry Association, entrusted by Zhejiang Emergency Management Department, organized and held the review meeting of "Demonstration of Safety and Reliability of Chemical Process Used for the First time in China" for high-performance PAN fiber in Hangzhou. Seiko Technology received a reply letter on December 10th.